Literature DB >> 16607460

No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population.

Parvaneh Keshavarz1, Hiroshi Inoue2, Yukiko Sakamoto1, Kiyoshi Kunika1, Toshihito Tanahashi1, Naoto Nakamura3, Toshikazu Yoshikawa3, Natsuo Yasui4, Hiroshi Shiota5, Mitsuo Itakura1.   

Abstract

Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1, also known as PC-1) inhibits insulin signal transduction pathway(s). Previous studies have demonstrated the K121Q variant of the ENPP1 gene to have a significant functional role in determining susceptibility to insulin resistance and type 2 diabetes (T2D). To assess whether the K121Q variant has any impact on T2D in Japanese, we undertook an extensive case-control association study using a total of 911 unrelated Japanese T2D patients and 876 control subjects. No significant difference was observed in either genotype distribution (P=0.95) or allele frequency (P=0.83) between T2D and control groups. Notably, the frequency of the ancestral Q121 allele, which is also present in other primates, was quite high in African-Americans, and showed a marked ethnic variation (77.3% in African-Americans, 16.7% in European Americans, 10.5% in Japanese and 4.2% in Han Chinese). Consequently, the pairwise F(ST )value (a classic measure of genetic distance between pairs of population) showed highly significant differentiations between African-American and non-African-American populations (F(ST)>0.3). Our results indicated that the K121Q variant of the ENPP1 gene has very little, if any, impact on T2D susceptibility in Japanese, but may play a role in the inter-ethnic variability in insulin resistance and T2D.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16607460     DOI: 10.1007/s10038-006-0399-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

1.  SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population.

Authors:  Yukiko Sakamoto; Hiroshi Inoue; Parvaneh Keshavarz; Katsuyuki Miyawaki; Yuka Yamaguchi; Maki Moritani; Kiyoshi Kunika; Naoto Nakamura; Toshikazu Yoshikawa; Natsuo Yasui; Hiroshi Shiota; Toshihito Tanahashi; Mitsuo Itakura
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

2.  Amerindians show no association of PPAR-γ2 gene Ala12 allele and obesity: an "unthrifty" variant population genetics.

Authors:  Antonio Arnaiz-Villena; Mercedes Fernández-Honrado; Cristina Areces; Mercedes Enríquez-de-Salamanca; Sedeka Abd-El-Fatah-Khalil; Carmen Coca; Ignacio Arribas; Manuel Algora; Diego Rey
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

3.  Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects.

Authors:  Philip J Lupo; Laura E Mitchell; Mark A Canfield; Gary M Shaw; Andrew F Olshan; Richard H Finnell; Huiping Zhu
Journal:  Mol Genet Metab       Date:  2013-11-18       Impact factor: 4.797

4.  The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population.

Authors:  Hamzeh Saberi; Narges Mohammadtaghvaei; Shekufeh Gulkho; Salar Bakhtiyari; Mohammad Mohammadi; Parichehr Hanachi; Siavash Gerayesh-Nejad; Mehryar Zargari; Farangis Ataei; Leila Parvaneh; Bagher Larijani; Reza Meshkani
Journal:  Mol Cell Biochem       Date:  2010-12-14       Impact factor: 3.396

5.  ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes in North Indians.

Authors:  Jasvinder Singh Bhatti; G K Bhatti; S S Mastana; S Ralhan; A Joshi; R Tewari
Journal:  Mol Cell Biochem       Date:  2010-09-04       Impact factor: 3.396

6.  Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects.

Authors:  N Grarup; S A Urhammer; J Ek; A Albrechtsen; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2006-07-25       Impact factor: 10.122

7.  Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.

Authors:  Yuka Takahama; Hirofumi Uto; Shuji Kanmura; Makoto Oketani; Akio Ido; Kazunori Kusumoto; Satoru Hasuike; Kenji Nagata; Katsuhiro Hayashi; Sherri Stuver; Akihiko Okayama; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

8.  The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.

Authors:  Allan F Moore; Kathleen A Jablonski; Clinton C Mason; Jarred B McAteer; Richard F Arakaki; Barry J Goldstein; Steven E Kahn; Abbas E Kitabchi; Robert L Hanson; William C Knowler; Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-11-18       Impact factor: 5.958

Review 9.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

Review 10.  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.

Authors:  Sang-Yong Lee; Christa E Müller
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.